UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000009594
Receipt No. R000011212
Official scientific title of the study Randmized Controlled Trial for validity and safety to effect of high hemoglobin(Hb) level on kidney function post kidney transplant recipients.
Date of disclosure of the study information 2012/12/21
Last modified on 2017/07/19 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Randmized Controlled Trial for validity and safety to effect of high hemoglobin(Hb) level on kidney function post kidney transplant recipients.
Title of the study (Brief title) Clinical study in anemia post kidney transplant recipients
Region
Japan

Condition
Condition Chronic kidney disease after kidney transplantation
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To study the optimal range of anemia after kideny transplantation
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Difference between Hb normal group and Hb subnormal group in rate of decline in kidney function for 5 years
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Hb normal group
Target Hb level 13g/dl with erythropoietin stimulating agents(ESA)
Interventions/Control_2 Hb subnormal group
Target Hb level 11g/dl with or without erythropoietin stimulating agents(ESA)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria 1.More than 1 year after kidney transplantation
2.Stable kidney function for at least 3 months
3.eGFR of 15-50 ml/min/1.73m2
4.Hb level of 9.0-11.5 g/dl with or without ESA
5.Patients who give written informed consent
Key exclusion criteria 1.Urine protein more than 1g/day
2.Deterionation of kidney function within the preceding 3 months
3.History of acute rejection within 3 months
4.Uncontrolled hypertension(systolic blood pressure>140,diastolic blood pressure>100)
5.Active or uncontrolled infection
6.Prior diagnosis of malignancy
7.Iron deficiency anemia
8.Hemorrhage diathesis
9.Hb<10g/dl with ESA
10.Pregnancy or lactation
11.History of myocardial infarctioin or angina pectoris
12.History of cerebral infarction with any symptom
13.Hypersensitivity reactions to ESA
Target sample size 100

Research contact person
Name of lead principal investigator Yoshihiko Watarai
Organization Nagoya Daini Red Cross Hospital
Division name Transplant Surgery
Address 2-9 Myoken-cho Syowa-ku Nagoya-shi
TEL 052-832-1121
Email watarai@nagoya2.jrc.or.jp

Public contact
Name of contact person Makoto Tsujita
Organization Nagoya Daini Red Cross Hospital
Division name Transplant Surgery
Address 2-9 Myoken-cho Syowa-ku Nagoya-shi
TEL 052-832-1121
Homepage URL
Email tsujita4850@nagoya2.jrc.or.jp

Sponsor
Institute Nagoya Daini Red Cross Hospital
Institute
Department

Funding Source
Organization Nagoya Daini Red Cross Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Masuko Memorial Hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 12 Month 21 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 05 Month 24 Day
Anticipated trial start date
2011 Year 12 Month 01 Day
Last follow-up date
2017 Year 07 Month 19 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 12 Month 20 Day
Last modified on
2017 Year 07 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011212